DEESIDE scaffolding and specialist contracts group, NSG UK, is reporting a 10% rise in sales in 2010, to £18m.
In May last year, the firm was subject to a management buyout led by managing director Michael Carr.
Liverpool-born Mr Carr describes NSG as a “multi-disciplined contractor”.
As well as providing scaffolding for the industrial and construction sectors, it also offers a range of other services that includes thermal insulation, industrial painting, blasting, specialist cleaning and more recently rail.
It has won a number of new clients over the past 12 months, and has grown staff numbers to 450.
Contracts secured include a three- year deal in Speke with global pharmaceutical firm Eli Lilly, construction works for Vinci at Whiston Hospital, and a £65m bio-energy facility being built by drinks giant Diageo, in Fife, Scotland.
Mr Carr said that, despite the recession hitting the construction and property sector, NSG had maintained a strong position.
He added: “This has been a dynamic year for us and, despite the rough waters, we have continued to increase turnover, win clients and grow the NSG UK brand.
“We have maintained growth in the construction and engineering sectors while expanding into the rail, social housing, marine and off-shore, and oil and gas sectors.
“We also see the resurgent nuclear industry as a key market for NSG UK, and we are always looking at ways to expand our portfolio.”
NSG had been acquired by MWB in February, 2008, but was purchased back in the buyout last year.
Mr Carr said: “NSG UK has been in existence, under various guises, for the past 40 years, and it is testimony to our credibility and performance that over that time we have built solid relationships with illustrious clients such as Ineos Chlor Vinyls, Ineos Enterprises, Centrica, Corus, Cammell Laird and Lilly.”